DEF 14A

Company

PLUS THERAPEUTICS, INC.

Filed

July 10, 2024

Period of Report

August 15, 2024

Accession Number

0001140361-24-032783

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →